dc.contributor.advisor |
Windahl, Charlotta |
|
dc.contributor.author |
McPadden, Millie |
|
dc.date.accessioned |
2022-10-06T01:40:24Z |
|
dc.date.available |
2022-10-06T01:40:24Z |
|
dc.date.issued |
2022 |
en |
dc.identifier.uri |
https://hdl.handle.net/2292/61529 |
|
dc.description.abstract |
The direct-to-consumer genetic testing (DTC-GT) and the wider genetic testing market are
changing. However, the DTC model of provision of genetic testing has been plagued by
controversies. Since its emergence in the early 2000’s, issues with the legitimacy of tests,
regulatory matters, and a lack of a healthcare professional have resulted in a negative
perception of DTC-GT. More recently, those who want to pursue the benefits of DTC-GT (such
as preventative and personalised medicine) are attempting to right these wrongs by using
healthcare professionals and engaging with regulatory authorities. However, these actors are
still struggling to pursue the benefits of DTC-GT. Previous literature has detailed these
controversies and opportunities; however, there is a lack of understanding of how actors are
shaping the market. As such, this study uses dynamic market systems literature, which sees
markets as being constantly shaped to investigate the market shaping activities of actors in the
clinical DTC-GT market.
This study used an abductive qualitative research approach to explore market-shaping
activities. Data was collected from 11 semi-structured interviews to analyse how actors trigger
and facilitate change in the clinical DTC-GT market. The findings show that technology is redesigning
exchange in the market, thus triggering change in the market. This enables other
actors to trigger change through other activities (e.g. re-configuring the network). Additionally,
market shaping activities are context-dependent. In the case of the DTC-GT market, actors
engage in ethical sense-making activities that ultimately shape how they trigger the market.
This is unique to the DTC-GT and genetic testing context as genetics. These findings are
helpful to those looking to or have implemented a clinical DTC genetic test as it provides details
on how actors are shaping the market and provides foresight to any potential struggles they
may face. |
|
dc.publisher |
ResearchSpace@Auckland |
en |
dc.relation.ispartof |
Masters Thesis - University of Auckland |
en |
dc.relation.isreferencedby |
UoA |
en |
dc.rights |
Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. |
|
dc.rights.uri |
https://researchspace.auckland.ac.nz/docs/uoa-docs/rights.htm |
en |
dc.rights.uri |
http://creativecommons.org/licenses/by-nc-nd/3.0/nz/ |
|
dc.title |
Market Shaping Activities in the Direct-to-Consumer Clinical Genetic Testing Market |
|
dc.type |
Thesis |
en |
thesis.degree.discipline |
Bioscience Enterprise |
|
thesis.degree.grantor |
The University of Auckland |
en |
thesis.degree.level |
Masters |
en |
dc.date.updated |
2022-09-05T05:04:49Z |
|
dc.rights.holder |
Copyright: the author |
en |
dc.rights.accessrights |
http://purl.org/eprint/accessRights/OpenAccess |
en |